Are changes in olanzapine-induced liver enzyme levels associated with GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms?

Olanzapine treatment sometimes produces transient liver biochemistry abnormalities, and such drug-induced liver injuries are mainly monitored by measuring blood levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), whereas alpha-glutathione-S-transferase (α-GST) is not routi...

Full description

Bibliographic Details
Main Authors: Elkama Aylin, İlik Nazlıcan, Ak Mehmet, Karahalil Bensu
Format: Article
Language:English
Published: Sciendo 2024-03-01
Series:Arhiv za Higijenu Rada i Toksikologiju
Subjects:
Online Access:https://doi.org/10.2478/aiht-2024-75-3770
_version_ 1797229597388963840
author Elkama Aylin
İlik Nazlıcan
Ak Mehmet
Karahalil Bensu
author_facet Elkama Aylin
İlik Nazlıcan
Ak Mehmet
Karahalil Bensu
author_sort Elkama Aylin
collection DOAJ
description Olanzapine treatment sometimes produces transient liver biochemistry abnormalities, and such drug-induced liver injuries are mainly monitored by measuring blood levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), whereas alpha-glutathione-S-transferase (α-GST) is not routinely measured in clinics, even though it can serve as an earlier and more specific biomarker of liver damage. Susceptibility to drug-induced liver injury can much depend on the gene polymorphisms regulating the activity of DNA detoxification and repair enzymes. The aim of this study was to evaluate which of the three liver enzymes – α-GST, ALT, and AST – is the most sensitive biomarker of olanzapine-induced liver injury and how their blood levels are affected by the GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms in 30 olanzapine-treated patients. Contrary to our hypothesis, the increase in serum α-GST levels was not significantly greater than that of the transaminases. ALT turned out to be an earlier biomarker of liver injury than the other two enzymes. No significant association was found between gene polymorphisms and liver enzyme levels, save for GSTP1 Ile/Val + Val/Val and ALT, which points to this genotype as a risk factor for drug-induced liver injury. Future studies might help to identify the underlying mechanisms of transient liver enzyme increase associated with this genotype.
first_indexed 2024-04-24T15:15:07Z
format Article
id doaj.art-98524015860c448099de182242aa8b25
institution Directory Open Access Journal
issn 1848-6312
language English
last_indexed 2024-04-24T15:15:07Z
publishDate 2024-03-01
publisher Sciendo
record_format Article
series Arhiv za Higijenu Rada i Toksikologiju
spelling doaj.art-98524015860c448099de182242aa8b252024-04-02T09:28:46ZengSciendoArhiv za Higijenu Rada i Toksikologiju1848-63122024-03-01751616710.2478/aiht-2024-75-3770Are changes in olanzapine-induced liver enzyme levels associated with GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms?Elkama Aylin0İlik Nazlıcan1Ak Mehmet2Karahalil Bensu3Gazi University Faculty of Pharmacy, Department of Toxicology, Ankara, TurkeyGazi University Faculty of Pharmacy, Department of Toxicology, Ankara, TurkeyNecmettin Erbakan University, Meram Faculty of Medicine, Department of Psychiatry, Konya, TurkeyGazi University Faculty of Pharmacy, Department of Toxicology, Ankara, TurkeyOlanzapine treatment sometimes produces transient liver biochemistry abnormalities, and such drug-induced liver injuries are mainly monitored by measuring blood levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), whereas alpha-glutathione-S-transferase (α-GST) is not routinely measured in clinics, even though it can serve as an earlier and more specific biomarker of liver damage. Susceptibility to drug-induced liver injury can much depend on the gene polymorphisms regulating the activity of DNA detoxification and repair enzymes. The aim of this study was to evaluate which of the three liver enzymes – α-GST, ALT, and AST – is the most sensitive biomarker of olanzapine-induced liver injury and how their blood levels are affected by the GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms in 30 olanzapine-treated patients. Contrary to our hypothesis, the increase in serum α-GST levels was not significantly greater than that of the transaminases. ALT turned out to be an earlier biomarker of liver injury than the other two enzymes. No significant association was found between gene polymorphisms and liver enzyme levels, save for GSTP1 Ile/Val + Val/Val and ALT, which points to this genotype as a risk factor for drug-induced liver injury. Future studies might help to identify the underlying mechanisms of transient liver enzyme increase associated with this genotype.https://doi.org/10.2478/aiht-2024-75-3770α-gstaltastdrug-induced liver injurymental disorderspsychotropic drugsα-gstaltastmentalni poremećajilijekom prouzročeno oštećenje jetrepsihotropni lijekovi
spellingShingle Elkama Aylin
İlik Nazlıcan
Ak Mehmet
Karahalil Bensu
Are changes in olanzapine-induced liver enzyme levels associated with GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms?
Arhiv za Higijenu Rada i Toksikologiju
α-gst
alt
ast
drug-induced liver injury
mental disorders
psychotropic drugs
α-gst
alt
ast
mentalni poremećaji
lijekom prouzročeno oštećenje jetre
psihotropni lijekovi
title Are changes in olanzapine-induced liver enzyme levels associated with GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms?
title_full Are changes in olanzapine-induced liver enzyme levels associated with GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms?
title_fullStr Are changes in olanzapine-induced liver enzyme levels associated with GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms?
title_full_unstemmed Are changes in olanzapine-induced liver enzyme levels associated with GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms?
title_short Are changes in olanzapine-induced liver enzyme levels associated with GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms?
title_sort are changes in olanzapine induced liver enzyme levels associated with gstt1 gstm1 gstp1 and ogg1 gene polymorphisms
topic α-gst
alt
ast
drug-induced liver injury
mental disorders
psychotropic drugs
α-gst
alt
ast
mentalni poremećaji
lijekom prouzročeno oštećenje jetre
psihotropni lijekovi
url https://doi.org/10.2478/aiht-2024-75-3770
work_keys_str_mv AT elkamaaylin arechangesinolanzapineinducedliverenzymelevelsassociatedwithgstt1gstm1gstp1andogg1genepolymorphisms
AT iliknazlıcan arechangesinolanzapineinducedliverenzymelevelsassociatedwithgstt1gstm1gstp1andogg1genepolymorphisms
AT akmehmet arechangesinolanzapineinducedliverenzymelevelsassociatedwithgstt1gstm1gstp1andogg1genepolymorphisms
AT karahalilbensu arechangesinolanzapineinducedliverenzymelevelsassociatedwithgstt1gstm1gstp1andogg1genepolymorphisms